Introduction
============

*Staphylococcus epidermidis* is one of the most important causes of nosocomial and community acquired infections ([@B16]). It is often observed in the device related and surgical site infections, where the biofilm formation on implants and tissues further increases the treatment failure ([@B7]; [@B9]; [@B16]). In addition, infections associated with biofilms are persisting until the subsequent replacement or removal of implants, which causes distress to patients and lead to superfluous expenditure ([@B12]). The available antibiotic therapy can only kill planktonic cells, leaving the bacterial cells to grow within the biofilms continuously even after the termination of antibiotic therapy ([@B44]; [@B38]; [@B42]). Alarmingly, the ability of biofilm to resist clearance by antibiotics increased the importance of a continuous search for novel antibacterial agents that target both planktonic and biofilm populations. Hence, new antibacterial agents are needed to combat biofilm mediated infections caused by *S. epidermidis*.

Throughout human history, plants have been the inexhaustible source of novel bioactive compounds with multitude of blockbuster therapeutic drugs, which have been derived directly or indirectly from various plants ([@B25]; [@B34]; [@B52]; [@B39]; [@B29]; [@B46]; [@B24]). Among the reported plant-derived bioactive compounds, alpha-mangostin (α-MG), a natural xanthone derived from the pericarp of *Garcinia mangostana* has been reported for various pharmacological properties that includes antibacterial, antifungal, anti-inflammatory, anticancer, and antioxidant activity ([@B20]). α-MG elicits *in vitro* rapid bactericidal activity against several Gram-positive pathogens ([@B36]; [@B26]; [@B49]). As reported by [@B26] α-MG rapidly disintegrates the cytoplasmic membrane integrity of methicillin resistant *Staphylococcus aureus* (MRSA), which results in loss of cytoplasmic components. The multi-step resistance selection assay from previous studies suggested that Gram-positive pathogens do not develop resistance against α-MG ([@B26]; [@B49]). Most importantly, data from our previous study confirmed that α-MG effectively inhibits the onset of biofilm formation as well as disrupts the immature and mature biofilms of *S. epidermidis* RP62A biofilms, though the highest concentration of vancomycin was inefficient in killing the sessile cells of *S. epidermidis* RP62A ([@B49]). Similarly, [@B35] reported that topical application of α-MG can effectively disrupt the development and structural integrity of *Streptococcus mutans* biofilm, which facilitates the mechanical clearance of cariogenic biofilms. Besides, several studies have demonstrated efficient methods to synthesize α-MG derivatives that also reflects the importance of α-MG and its derivatives in biological research ([@B32]; [@B18]; [@B58]; [@B61]; [@B15]; [@B27]; [@B30]; [@B28]). The potential bottleneck to develop α-MG as an effective antibacterial agent is the very limited understanding of the molecular mechanism of action of α-MG. Indeed, several studies have used omics techniques to elucidate the antibacterial mode of action of plant-derived compounds ([@B41]; [@B13]). Though, the rapid antibacterial mode of action of α-MG has been already investigated through *in vitro* and *in silico* approaches ([@B26]), integrated advanced omics technologies will further augment the current knowledge on the mode of action of α-MG. In the present study, we investigated the molecular mechanism of antibacterial activity of α-MG through an integrated transcriptomic and proteomic approach.

Materials and Methods {#s1}
=====================

Bacterial Strain and Chemical
-----------------------------

*Staphylococcus epidermidis* RP62A (ATCC 35984) was routinely grown in Luria-Bertani (LB; HiMedia, India) and was maintained in LB with 30% glycerol at -80°C. α-MG was purchased from Sigma-Aldrich (Catalog No.: M3824) and stock solution of 1 mg/mL was prepared in methanol.

Antibacterial Assays
--------------------

The minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and time kill kinetics assays were previously determined ([@B49]). The MIC and MBC values of α-MG were determined again to precede subsequent assays ([@B8]). The spot assay was carried out to determine the antibacterial activity of α-MG on mid-log phase cultures. Different concentrations of α-MG \[1.25 μg/mL (MIC), 0.875 μg/mL (0.7 MIC), 0.625 μg/mL (0.5 MIC), 0.3125 μg/mL (0.25 MIC)\] were added to mid-log phase (∼2.5 × 10^8^ CFU/ml) cultures that were subsequently incubated at 37°C for 10 min. After incubation, 10 μl of serially diluted control (0.1% methanol) and α-MG treated samples were spotted on LB plates. The plates were incubated at 37°C for 18 h.

RNA-Sequencing and Data Analysis
--------------------------------

Overnight cultures of *S. epidermidis* were diluted in 1:100 in LB and were grown to mid-log phase (∼2.5 × 10^8^ CFU/ml) at 37°C. Bacterial cells were treated with 0.7 MIC (0.875 μg/ml) of α-MG or 0.1% methanol (solvent control) for 10 min. After incubation, 2 volumes of RNAprotect Bacteria Reagent (Qiagen, Hilden, Germany) were added to one volume of bacterial cultures. Then, the cells were pelleted by centrifugation, resuspended in 200 μl of TE buffer containing 15 mg/ml of lysozyme and 10 μl of proteinase K and incubated at 37°C for 30 min. After incubation, zirconia beads (50 mg; 0.1 mm) were added to lyse the cells using FastPrep 24 instrument (Qbiogene, Heidelberg, Germany) and the total RNA was extracted using RNeasy Mini kit (Qiagen, Hilden, Germany). To remove genomic DNA, on-column DNA digestion was done using RNase-Free DNase set (Qiagen, Hilden, Germany). The RNA integrity was analyzed using LabChip GXII Touch HT (PerkinElmer, United States). The ribosomal RNA (rRNA) was depleted using Ribo-Zero rRNA Removal kit for Gram-positive bacteria (Illumina, San Diego, CA, United States). Sequencing library was prepared as described before with modifications ([@B31]). The libraries were sequenced in Biomedicum Functional Genomics Unit (Helsinki, Finland). Reverse transcription of mRNA was performed using specially designed primers. Similarly to the method described in [@B31], all the primers shared a common sequence that served as a PCR handle. Additionally, the primers contained known 12 bp barcode (unique for each sample) and different random unique molecular identifiers (UMIs) ([@B31]). The poly (T) regions of the oligos were replaced by random hexamers to enable the capturing of the bacterial mRNA particles. The reverse transcription, PCR amplification of the cDNA and tagmentation were performed as described by [@B31]. Paired-end sequencing was performed on NextSeq500 sequencer (Illumina) using the sequencing primers ([@B31]). Sequencing in 75 cycles produced 20 bp Read 1 (bases 1--12 sample barcode, bases 13--20 UMI) and 55 bp Read 2 (sequence derived from the bacterial mRNA). The raw sequencing reads were analyzed using the Dropseq Core Computational Protocol ([@B31]). The obtained sequencing reads were aligned against the strain *S. epidermidis* RP62A (ATCC 35984) genome using the STAR aligner ([@B11]). The edgeR, a Bioconductor package was used to obtain the list of differentially expressed genes ([@B43]). The RNA sequence data has been deposited to NCBI Gene Expression Omnibus (Accession No.: GSE113302).

Quantitative Proteomics
-----------------------

The mid-exponential growth phase (∼2.5 × 10^8^ CFU/ml) cultures were treated with 0.7 MIC (0.875 μg/ml) of α-MG or 0.1% methanol (solvent control) for 10 and 30 min. After incubation, α-MG treated and untreated cells were harvested by centrifugation at 3500 × *g*, washed with sterile PBS and resuspended in 1 ml of lysis buffer (0.1% RapiGest, 8 M urea, 100 mM ammonium bicarbonate). The cell suspension was sonicated for 10 min (Branson Sonifier 450; 30 s running, 30 s pause, pulsed mode 30%) and stored at -70°C. Prior to trypsin digestion of proteins, the protein samples were reduced with Tris (2-carboxyethyl) phosphine and alkylated with iodoacetamide. Subsequently, tryptic peptide digests were purified using C18 reversed-phase columns ([@B51]) and the mass spectrometric analysis was performed in Orbitrap Elite ETD mass spectrometer (Thermo Scientific), using Xcalibur version 2.7.1 coupled with a Thermo Scientific nLCII nanoflow HPLC system. MS peak extraction and subsequent protein identification was analyzed using Proteome Discoverer software (Thermo Scientific). Calibrated peak files were searched against the *S. epidermidis* RP62A proteins (Uniprot) by a SEQUEST search engine. Error tolerance on the fragment and precursor ions were +0.8 Da and +15 p.p.m, respectively. For peptide identification, a stringent cut-off value (0.5% false discovery rate, FDR) was used.

Bioinformatics Tools
--------------------

Gene ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway assignations were carried out to determine the function of differentially regulated genes, using STRING (version 10.5) with high confidence score of 0.7 ([@B5]). Categories with a *p*-value ≤ 0.05 were set as statistically significant for gene enrichment. Differentially expressed hypothetical proteins were analyzed for putative functions using protein BLAST to search Pfam (protein families) domains in a Pfam database (version 31.0) and subcellular localization was predicted using PSORTb ([@B59]). The differentially expressed genes were also analyzed in the CELLO2GO^[1](#fn01){ref-type="fn"}^ to retrieve the sub-cellular localization and functional GO annotation against Gram-positive bacteria with an *E*-value 0.001 ([@B60]).

Experimental Validation Using Quantitative Real-Time-PCR (qRT-PCR)
------------------------------------------------------------------

Twenty-one differentially expressed genes were selected for validation using qRT-PCR. The gene specific primers were designed using Primer3 software (version 0.4.0). The details of primers are listed in [Supplementary Table 1](#SM1){ref-type="supplementary-material"}. Total RNA was isolated as described above and cDNA was synthesized using Superscript III kit (Invitrogen Inc., United States) as per the manufacturer's instructions. The qRT-PCR reaction was performed in 7500 Sequence Detection System (Applied Biosystems Inc., Foster, CA, United States). The mRNA expression patterns of selected genes were normalized against constitutively expressed two internal controls (16S*rRNA* and *rplU*) and quantified using 2^-ΔΔCt^ method. Three independent experiments were carried out in duplicate. Statistical significance was analyzed using unpaired Student *t*-test and considered significant at *P* \< 0.05.

Results
=======

Determination of α-MG Concentration for Transcriptomic and Proteomic Profiling Studies
--------------------------------------------------------------------------------------

The MIC and MBC of α-MG was found to be 1.25 and 5 μg/mL, respectively, which substantiates the results obtained from the previous study ([@B49]). Besides, [@B49] have already reported the rapid bactericidal property of α-MG against *S. epidermidis* cells, where it displayed 6 log (4× MIC; 5 μg/mL) and 4 log (2× MIC; 2.5 μg/mL) reduction of viable count within 5 min of exposure time ([@B49]). Since transcriptional profiling is typically performed by the addition of antibacterial agents to mid-log phase cultures, spot assay was carried out to choose the concentration and duration of α-MG treatment. Based on the results, 0.7 MIC (0.875 μg/mL) of α-MG was chosen for 10 min and 30 min of antibacterial challenge with *S. epidermidis* ([Supplementary Figure 1](#SM1){ref-type="supplementary-material"}).

Global Transcriptome and Proteome Response to α-MG Treatment
------------------------------------------------------------

### Transcriptome Analysis

To uncover the antibacterial mode of action of α-MG, RNA sequencing was performed from α-MG treated (0.7 MIC, 10 min) and untreated *S. epidermidis* RP62A cells. A total of 2,411 genes were identified under both the conditions, which correspond to 91.84% of *S. epidermidis* RP62A (2,625 genes in GenBank). Of 2,411 genes, the edgeR analysis revealed differential expression of 98 genes (4.06%) with ≥1.5-fold difference in log FC (log fold change) with *P* \< 0.001, wherein 48 (1.9%) genes were upregulated while the remaining 50 (2.07%) genes were downregulated in response to α-MG treatment. The details of differentially regulated genes, their role and the log FC are listed in [Table 1](#T1){ref-type="table"}. Besides, 33.6% (33/98) of differentially regulated genes were encoding uncharacterized proteins. Hence, identities of protein families and sub-cellular localization of hypothetical proteins were predicted accordingly using Pfam and PSORTb ([Supplementary Table 2](#SM1){ref-type="supplementary-material"}). In addition, 30.3% (10/33), 27.2% (9/33), 3% (1/33), and 39.3% (13/33) of the hypothetical proteins were predicted to be localized in the cytoplasmic membrane-associated, cytoplasic, extracellular and location-unknown, respectively.

###### 

List of differentially expressed genes of *S. epidermidis* treated with α-MG identified using RNA sequencing.

  Gene ID    Gene      Product                                                                   log FC   *P*-value
  ---------- --------- ------------------------------------------------------------------------- -------- ----------------
  SERP1987   *narG*    Respiratory nitrate reductase, alpha subunit                              2.56     3.47 × 10^-23^
  SERP0257   *adh*     Alcohol dehydrogenase, zinc-containing                                    1.95     2.12 × 10^-18^
  SERP2080   *aldA*    Aldehyde dehydrogenase family protein                                     2.20     6.47 × 10^-18^
  SERP2142   *ansP*    Amino acid permease family protein                                        2.70     3.98 × 10^-17^
  SERP1784             Conserved hypothetical protein                                            2.12     5.32 × 10^-17^
  SERP2327             Acetoin dehydrogenase, E3 component, dihydrolipoamide dehydrogenase       1.89     1.71 × 10^-14^
  SERP2365   *pflA*    Pyruvate formate lyase activating enzyme                                  1.61     2.10 × 10^-13^
  SERP0244             Oxidoreductase, aldo/ketoreductase family                                 2.04     3.91 × 10^-13^
  SERP1986   *narH*    Respiratory nitrate reductase, beta subunit                               1.74     4.21 × 10^-12^
  SERP0245   *YdfJ*    Transporter, putative                                                     233      9.35 × 10^-12^
  SERP1783             Conserved hypothetical protein                                            1.66     1.21 × 10^-11^
  SERP2112   *adh2*    Alcohol dehydrogenase, zinc-containing                                    1.79     3.85 × 10^-11^
  SERP2412   *mqo-4*   Malate:quinone oxidoreductase                                             1.38     8.56 × 10^-11^
  SERP2366   *pflB*    Formate acetyltransferase                                                 1.40     1.44 × 10^-10^
  SERP1990   *nirB*    Nitrite reductase \[NAD(P)H\], large subunit                              2.17     1.56 × 10^-10^
  SERP2324             Acetoin dehydrogenase, E2 component, dihydrolipoamide acetyltransferase   1.34     3.30 × 10^-10^
  SEA0017    *yadH*    ABC transporter, permease protein                                         1.98     5.79 × 10^-10^
  SERP2325   *acoB*    Acetoin dehydrogenase, E1 component, beta subunit                         1.47     1.68 × 10^-09^
  SEA0018    *ccmA*    ABC transporter, ATP-binding protein                                      2.02     3.86 × 10^-09^
  SERP0419             Ribosomal subunit interface protein                                       1.23     8.43 × 10^-09^
  SERP0897   *hom*     Homoserine dehydrogenase                                                  3.25     1.20 × 10^-08^
  SERP2029             Amino acid ABC transporter, amino acid-binding protein                    1.50     1.80 × 10^-08^
  SERP0270             Conserved hypothetical protein                                            1.27     2.15 × 10^-08^
  SERP2326             Acetoin dehydrogenase, E1 component, alpha subunit                        1.63     3.39 × 10^-08^
  SERP0336             Conserved hypothetical protein                                            2.02     3.46 × 10^-08^
  SERP1988   *sumT*    Uroporphyrinogen-III methylaseSirB, putative                              1.85     1.02 × 10^-07^
  SERP0216             Hexulose phosphate synthase, putative                                     1.31     1.05 × 10^-07^
  SERP1782             Alkaline shock protein 23                                                 1.15     1.11 × 10^-07^
  SERP2469   *frmA*    Alcohol dehydrogenase, zinc-containing                                    2.19     2.78 × 10^-07^
  SERP2031             Amino acid ABC transporter, ATP-binding protein                           1.37     4.38 × 10^-07^
  SERP1985   *narJ*    Respiratory nitrate reductase, delta subunit                              2.07     9.87 × 10^-07^
  SERP1980             Nitrite extrusion protein                                                 2.11     2.91 × 10^-06^
  SERP1476             Conserved hypothetical protein                                            3.30     3.84 × 10^-06^
  SERP1484   *groEL*   Chaperonin, 60 kDa                                                        0.95     4.08 × 10^-06^
  SERP1483             Cell wall surface anchor family protein                                   0.99     4.23 × 10^-06^
  SERP0665             Hypothetical protein                                                      2.45     6.17 × 10^-06^
  SERP1719   *glyA*    Serine hydroxymethyltransferase                                           1.00     6.68 × 10^-06^
  SERP0348             Anion transporter family protein                                          1.39     7.93 × 10^-06^
  SERP0903   *katA*    Catalase                                                                  0.93     8.30 × 10^-06^
  SERP0444   *tpiA*    Triosephosphate isomerase                                                 1.09     1.24 × 10^-05^
  SERP1754             Conserved hypothetical protein                                            1.55     1.27 × 10^-05^
  SERP1413             ThiJ/PfpI family protein                                                  0.99     1.68 × 10^-05^
  SERP1785             Alcohol dehydrogenase, zinc-containing                                    1.51     1.69 × 10^-05^
  SERP1387   *fumC*    Fumarate hydratase, class II                                              0.94     2.42 × 10^-05^
  SERP1790   *lacE*    PTS system, lactose-specific IIBC components                              0.99     2.68 × 10^-05^
  SERP0364   *saeS*    Sensor histidine kinase                                                   0.90     3.83 × 10^-05^
  SERP1789   *lacG*    6-phospho-beta-galactosidase                                              0.96     4.00 × 10^-05^
  SERP0898   *thrC*    Threonine synthase                                                        2.49     5.33 × 10^-05^
  SERP1697   yidC2     Membrane protein insertase YidC 2                                         -1.70    1.60 × 10^-16^
  SERP0679   ykyA      Conserved hypothetical protein                                            -1.32    1.27 × 10^-12^
  SERP0518   dltA      [D]{.smallcaps}-alanine activating enzyme                                 -1.68    1.31 × 10^-11^
  SERP1948   tcaA      tcaA protein                                                              -1.40    1.74 × 10^-10^
  SERP2241             Transcriptional regulator, putative                                       -3.43    1.19 × 10^-09^
  SERP1088   accB      Acetyl-CoA carboxylase, biotin carboxyl carrier protein                   -2.12    1.23 × 10^-09^
  SERP1098   rhoD      Rhodanese like domain protein                                             -1.93    1.70 × 10^-09^
  SERP0674   trkA      Potassium uptake protein TrkA                                             -2.01    1.94 × 10^-09^
  SERP1738             Conserved hypothetical protein                                            -1.19    4.18 × 10^-09^
  SERP0466             Cold shock protein, CSD family                                            -1.65    6.00 × 10^-09^
  SERP1383   xre       Transcriptional regulator, Cro/CI family                                  -1.76    1.28 × 10^-08^
  SERP2314   yceI      Conserved hypothetical protein                                            -1.26    1.36 × 10^-08^
  SERP1761             Hypothetical protein                                                      -1.79    2.01 × 10^-08^
  SERP0541   yabR      General stress protein 13                                                 -2.02    2.07 × 10^-08^
  SERP0316   ykaA      Conserved hypothetical protein                                            -1.04    2.46 × 10^-08^
  SERP2138             Immunodominant antigen A, putative                                        -1.05    3.22 × 10^-08^
  SERP1472             Conserved hypothetical protein                                            -2.46    3.59 × 10^-08^
  SERP0517             Conserved hypothetical protein                                            -2.32    7.67 × 10^-08^
  SERP1381             Conserved hypothetical protein                                            -1.11    7.97 × 10^-08^
  SERP2254             Conserved hypothetical protein                                            -1.61    1.89 × 10^-07^
  SERP1330   *lytD*    *N*-acetylmuramoyl-[L]{.smallcaps}-alanine amidase, family 4              -1.11    2.01 × 10^-07^
  SERP0057             Conserved hypothetical protein                                            -1.69    2.73 × 10^-07^
  SERP0342   *norR*    Transcriptional regulator, MarR family                                    -1.06    3.59 × 10^-07^
  SERP1896             Abortive infection family protein                                         -1.78    4.38 × 10^-07^
  SERP0701             Conserved hypothetical protein                                            -1.20    4.43 × 10^-07^
  SERP1772             Conserved hypothetical protein                                            -1.39    8.17 × 10^-07^
  SERP0972             Cold shock protein, CSD family                                            -2.08    8.77 × 10^-07^
  SERP0919   *mscL*    Large conductance mechanosensitive channel protein                        -1.53    1.31 × 10^-06^
  SERP0013             Conserved hypothetical protein                                            -1.33    1.54 × 10^-06^
  SERP0001   *rpmH*    Ribosomal protein L34                                                     -2.37    1.95 × 10^-06^
  SERP2271             Conserved hypothetical protein                                            -2.07    2.95 × 10^-06^
  SERP0557             Conserved hypothetical protein                                            -1.39    3.64 × 10^-06^
  SERP1946             Transcriptional regulator, TetR family                                    -1.65    4.37 × 10^-06^
  SERP1952             ABC transporter, permease protein                                         -1.28    4.39 × 10^-06^
  SERP1154             Conserved hypothetical protein                                            -1.65    5.32 × 10^-06^
  SERP1382             Conserved hypothetical protein                                            -2.25    6.90 × 10^-06^
  SERP1694             Conserved hypothetical protein                                            -1.32    1.03 × 10^-05^
  SERP1280   *nifS*    Aminotransferase, class V                                                 -1.77    1.19 × 10^-05^
  SERP0639             Conserved hypothetical protein                                            -1.53    1.74 × 10^-05^
  SERP0717             Conserved hypothetical protein                                            -0.83    1.75 × 10^-05^
  SERP1093   *efp*     Translation elongation factor P                                           -0.94    1.86 × 10^-05^
  SERP2475             Conserved hypothetical protein                                            -1.40    2.38 × 10^-05^
  SERP1215             Conserved hypothetical protein                                            -1.42    2.72 × 10^-05^
  SERP1741   *luxS*    Autoinducer-2 production protein LuxS                                     -1.42    2.78 × 10^-05^
  SERP2202             Conserved hypothetical protein                                            -0.85    3.11 × 10^-05^
  SERP1664             Conserved hypothetical protein TIGR00150                                  -2.62    3.38 × 10^-05^
  SERP1707             Conserved hypothetical protein                                            -2.62    3.38 × 10^-05^
  SERP0048             Hypothetical protein                                                      -2.16    4.31 × 10^-05^
  SERP0297   *tagG*    tagG protein, teichoic acid ABC transporter protein, putative             -1.14    4.83 × 10^-05^
  SERP1236   *hemA*    Glutamyl-tRNA reductase                                                   -0.81    4.98 × 10^-05^
                                                                                                          

Differentially expressed genes after α-MG treatment in

S. epidermidis

were identified using edgeR software with \> 1.5 fold (given in log FC) and

P

\< 0.001.

The functional categorization for upregulated and downregulated genes was analyzed separately using STRING~10.5~. Subsequently, GO (biological process, molecular function and cellular component) analysis for differentially regulated genes were annotated manually and the interacting network maps are shown in [Figure 1A](#F1){ref-type="fig"}, [2A](#F2){ref-type="fig"}. According to GO annotation, the upregulated genes were scattered among various biological processes which included oxidation-reduction, metabolic, phosphorylation, nucleobase-containing small molecule metabolic, tricarboxylic acid (TCA) cycle and aerobic respiration processes ([Figure 1B](#F1){ref-type="fig"}). The predominant molecular functions of upregulated genes were catalytic activity, oxidoreductase activity and other molecular functions ([Figure 1C](#F1){ref-type="fig"}). Further, in the KEGG pathway analysis, the upregulated genes were shown to be involved in glycolysis/gluconeogenesis, TCA cycle, carbon metabolism, nitrogen metabolism, pyruvate metabolism, aminoacid biosynthesis, ABC transporters, RNA and fatty-acid degradation pathways ([Figure 3A](#F3){ref-type="fig"}). Meanwhile, GO annotation of downregulated genes were involved in various biological processes viz., protoporphyrinogen IX biosynthetic, heme-biosynthetic, cofactor biosynthetic, sulfur compound biosynthetic and malonyl-CoA biosynthetic processes ([Figure 2B](#F2){ref-type="fig"}). In addition, the KEGG pathway analysis indicated that the downregulated genes are involved in several metabolic pathways that include biosynthesis of secondary metabolites, fatty-acid biosynthesis, DNA replication and mismatch repair ([Figure 3B](#F3){ref-type="fig"}). Acetyl-CoA carboxylase complex (GO.0009317) was the only significant cellular component encoded by the downregulated genes. Furthermore, the CELLO2GO, used for functional GO annotation and sub-cellular localization for proteins encoded by differentially expressed genes ([Supplementary Figure 2](#SM1){ref-type="supplementary-material"}), substantiated the results obtained from STRING~10.5~ analysis. It has been reported to predict sub-cellular localization of proteins with 99.4% accuracy among Gram-positive bacteria ([@B60]). Among the proteins encoded by the 98 differentially expressed genes, 66.7, 18.9, 13.5, and 0.9% were predicted to be cytoplasmic, cytoplasmic membrane- associated, extracellular and cell wall-associated proteins, respectively.

![Interaction analysis of upregulated genes identified by RNA-sequencing. **(A)** Interactome map predicted using STRING~10.5~. The network nodes represent the proteins encoded by the genes. Edges represent protein-protein associations with high confidence score. The associations are meant to be specific and meaningful with associated proteins jointly contributing to a shared function. This does not necessarily mean that the proteins are physically binding each other, **(B)** significant biological process and **(C)** molecular function of upregulated genes.](fmicb-10-00150-g001){#F1}

![Significant GO annotation of downregulated genes identified by RNA-sequencing. **(A)** Interactome map predicted using STRING~10.5~. The network nodes represent the proteins encoded by the genes. Edges represent protein--protein associations with high confidence score. The associations are meant to be specific and meaningful with associated proteins jointly contributing to a shared function. This does not necessarily mean that the proteins are physically binding each other and **(B)** biological process of downregulated genes.](fmicb-10-00150-g002){#F2}

![The histogram summarizing the enriched KEGG pathways of differentially expressed genes identified using RNA-sequencing. **(A)** Upregulated pathways and **(B)** downregulated pathways upon α-MG treatment.](fmicb-10-00150-g003){#F3}

### Proteome Analysis

Proteomic profiling was employed to gain additional insights on the different cellular responses upon α-MG treatment. A total of 589 proteins were identified from all conditions, which corresponds to 23.51% of the predicted proteome (2505 proteins in UniProtKB database) of *S. epidermidis* RP62A. Prior to further analyses, Venn diagram ([Supplementary Figure 3](#SM1){ref-type="supplementary-material"}) was constructed to summarize the differences and similarities between proteins expressed in each conditions. It demonstrated that 492 proteins were expressed under all the conditions. Changes in proteome level were studied by comparing control cells with α-MG treated (0.7 MIC) cells at two different time points (10 and 30 min). Over all, differential expression (≥1.5-fold up- or down-regulation, *p* ≤ 0.05) of 89 proteins in response to α-MG treatment was observed: 34 proteins at 10 min (2 upregulated and 32 downregulated) and 70 proteins at 30 min (38 upregulated and 32 downregulated) ([Table 2](#T2){ref-type="table"}). However, only fifteen differentially expressed proteins (1 up- and 14 down-regulated) were found at both the time points. Of 89 proteins, 24 proteins were uncharacterized protein. The details of protein families and sub-cellular localization of uncharacterized proteins are listed in [Supplementary Table 3](#SM1){ref-type="supplementary-material"}. It was observed that most of the hypothetical proteins were localized in cytoplasmic membrane and cytoplasm ([Supplementary Table 3](#SM1){ref-type="supplementary-material"}). According to GO annotation, the upregulated and downregulated proteins are involved in various biological process and molecular function ([Figure 4](#F4){ref-type="fig"}). The protein-protein interaction maps of upregulated and downregulated proteins are shown in [Supplementary Figure 4](#SM1){ref-type="supplementary-material"}. The KEGG pathway analysis predicted that the most strongly upregulated proteins are ribosomal proteins, and the most strongly downregulated proteins are involved in various metabolic pathways that include nucleotide excision repair, ABC transporters and phosphotransferase system ([Figure 5](#F5){ref-type="fig"}). Besides, the GO annotation analysis of differentially regulated proteins using CELLO2GO is depicted in the [Supplementary Figure 5](#SM1){ref-type="supplementary-material"}. Among 89 differentially regulated proteins, 71, 15, and 11% were predicted to be cytoplasmic, membrane-associated, and extracellular proteins, respectively.

###### 

List of differentially expressed proteins of *S. epidermidis* treated with α-MG identified using LC-MS/MS.

  Gene ID        Gene         Product                                                                          0.7 MIC (10 min)   0.7 MIC (30 min)              
  -------------- ------------ -------------------------------------------------------------------------------- ------------------ ------------------ ---------- ---------------
  SERP1356                    Putative membrane protein insertion efficiency factor                                                                  9.87       0.04
  SERP0651       *purC*       Phosphoribosylaminoimidazole-succinocarboxamide synthase                                                               4.47       0.0003
  SERP0045       *ssb*        Single-stranded DNA-binding protein                                                                                    3.44       0.05
  SERP0496       *sufC*       FeS assembly ATPase SufC                                                                                               2.94       0.02
  SERP0403                    Transferrin receptor                                                                                                   2.78       0.04
  SERP0300       *tagD*       Glycerol-3-phosphate cytidylyltransferase                                                                              2.59       0.05
  SERP0946       *femA*       femA protein                                                                                                           2.33       0.06
  SERP0039                    Conserved hypothetical protein                                                                                         2.23       0.002
  SERP0679                    Conserved hypothetical protein (putative cell wall binding lipoprotein)                                                2.23       0.04
  SERP0170       *cysS*       Cysteinyl-tRNA synthetase                                                                                              2.14       0.01
  SERP1273                    Universal stress protein family                                                                                        2.14       0.02
  SERP0826       *frr*        Ribosome recycling factor                                                                                              2.12       0.01
  SERP1781                    Conserved hypothetical protein (IucA/IucC family)                                                                      2.06       0.05
  SERP0690                    Conserved hypothetical protein (protein of unknown function)                                                           2.05       0.03
  SERP2132       *copZ*       Heavy metal-binding protein, putative (Inorganic ion transport and metabolism)                                         1.98       0.003
  SERP0435                    Conserved hypothetical protein                                                                                         1.98       0.003
  SERP1431                    Ferritin family protein (Inorganic ion transport and metabolism)                                                       1.97       0.04
  SERP1956       *RfaB*       Glycosyltransferase, group 1 family protein                                                                            1.96       0.04
  SERP0139       *rplY*       Ribosomal protein L25                                                                                                  1.91       0.004
  SERP0179       *rplA*       Ribosomal protein L1                                                             1.66               0.04                          
  SERP0604                    Conserved hypothetical protein                                                                                         1.89       0.05
  SERP1187                    Bacterial luciferase family protein                                                                                    1.88       0.03
  SERP2046                    Exopolyphosphatase                                                                                                     1.86       0.003
  SERP1899       *murQ*       Glucokinase regulator-related protein                                                                                  1.83       0.04
  SERP0245       *YdfJ*       Transporter, putative (Uncharacterized membrane protein YdfJ)                                                          1.83       0.04
  SERP0587       *ppnK*       Conserved hypothetical protein                                                                                         1.81       0.03
  SERP1373                    HIT family protein                                                                                                     1.81       0.03
  SERP0791                    Conserved hypothetical protein (alkaline shock protein (Asp23) family)                                                 1.79       0.003
  SERP2047       *ppk*        Polyphosphate kinase                                                                                                   1.75       0.02
  SERP1132       *glyS*       Glycyl-tRNA synthetase                                                                                                 1.75       0.02
  **SERP0527**                **NADH dehydrogenase, putative**                                                 **1**.**53**       **0**.**05**       **1.77**   **0**.**01**
  SERP0151       cysK         Chaperonin, 33 kDa                                                                                                     1.66       0.007
  SERP1629                    Hypothetical protein SERP1629                                                                                          1.66       0.007
  SERP0580       *pepF*       Oligoendopeptidase F                                                                                                   1.65       0.01
  SERP0545       *rocD*       Ornithine aminotransferase                                                                                             1.64       0.01
  SERP0436       *clpP*       ATP-dependent Clp protease, proteolytic subunit ClpP                                                                   1.63       0.05
  SERP0195       *ilvE*       Branched-chain amino acid aminotransferase                                                                             1.62       0.04
  SERP0136       *spoVG*      spoVG protein                                                                                                          1.56       0.0005
  SERP0188       *fusA*       Translation elongation factor G                                                                                        1.53       0.007
  SERP0217                    SIS domain protein                                                                                                     -2.23      0.008
  **SERP0427**   ***uvrA***   **Excinuclease ABC, A subunit**                                                  **INF**            **0**.**02**       **INF**    **0**.**02**
  **SERP0312**   ***ompR***   **DNA-binding response regulator**                                               **INF**            **0**.**003**      **INF**    **0**.**003**
  SERP0525                    Conserved hypothetical protein                                                                                         INF        0.003
  SERP0738                    Phenol soluble modulin beta 1                                                                                          INF        0.003
  SERP0870                    tRNA delta(2)-isopentenylpyrophosphatetransferase                                                                      INF        0.003
  SERP0199                    Hydrolase, haloaciddehalogenase-like family                                                                            INF        0.003
  **SERP0764**   ***pyrR***   **Pyrimidine operon regulatory protein**                                         **INF**            **0**.**003**      **INF**    **0**.**026**
  **SERP0303**   ***abcA***   **ABC transporter, ATP-binding/permease protein**                                **INF**            **0**.**003**      **INF**    **0**.**008**
  SERP0749                    Cell division protein FtsQ, putative                                                                                   INF        0.003
  SERP2293       *icaA*       Intercellular adhesion protein A                                                                                       INF        0.003
  **SERP0409**                **Glycerate kinase family protein**                                              **INF**            **0**.**003**      **INF**    **0**.**003**
  SERP1872       *ureE*       Urease accessory protein UreE                                                                                          INF        0.003
  SERP1900                    PTS system, IIBC components                                                                                            INF        0.003
  **SERP1407**                **Conserved hypothetical protein**                                               **INF**            **0**.**003**      **INF**    **0**.**003**
  **SERP1131**                **Conserved hypothetical protein**                                               **INF**            **0**.**003**      **INF**    **0**.**003**
  **SERP0015**   ***lolD***   **ABC transporter, ATP-binding protein**                                         **INF**            **0**.**003**      **INF**    **0**.**003**
  **SERP2408**                **Conserved hypothetical protein**                                               **INF**            **0**.**003**      **INF**    **0**.**003**
  **SERP2131**                **Cation-transporting ATPase,E1-E2 family**                                      **INF**            **0**.**003**      **INF**    **0**.**003**
  **SERP2055**                **Phosphoglucomutase/phosphomannomutase family protein**                         **INF**            **0**.**003**      **INF**    **0**.**003**
  **SERP0323**                **Conserved hypothetical protein**                                               **INF**            **0**.**003**      **INF**    **0**.**003**
  **SERP0241**                **Conserved hypothetical protein**                                               **INF**            **0**.**003**      **INF**    **0**.**003**
  SERP1628                    Conserved hypothetical protein                                                                                         INF        0.003
  SERP0419       *raiA*       Ribosomal subunit interface protein                                              5.8                0.04                          
  SERP0742                    Conserved hypothetical protein                                                   INF                0.03                          
  SERP0846                    Peptidase, M16 family                                                            INF                0.02                          
  SERP0246                    ABC transporter, substrate-binding protein, putative                             INF                0.008                         
  SERP0447                    Conserved hypothetical protein                                                   INF                0.003                         
  SERP0512                    Conserved hypothetical protein                                                   INF                0.003                         
  **SERP0652**   ***purS***   **Phosphoribosylformylglycinamidine synthase, PurS protein**                     **INF**            **0**.**003**      **INF**    **0**.**003**
  SERP1704                    ywpF protein                                                                     INF                0.003                         
  SERP0206                    Azoreductase                                                                     INF                0.008                         
  SERP0423                    HD domain protein, putative                                                      INF                0.003                         
  SERP0654       *purL*       Phosphoribosylformylglycinamidine synthase II                                    INF                0.03                          
  SERP0866       *glpF*       Glycerol uptake facilitator protein                                              INF                0.05                          
  SERP2378       *ccmA*       ABC transporter, ATP-binding protein                                             INF                0.003                         
  SERP0774                    Conserved hypothetical protein                                                   INF                0.003                         
  SERP0297                    tagG protein, teichoic acid ABC transporter protein, putative                    INF                0.003                         
  SERP0891                    Thermonuclease precursor family protein                                          INF                0.003                         
  SERP1839       *gdh*        Glucose 1-dehydrogenase                                                          INF                0.05                          
  SERP0433                    Conserved hypothetical protein                                                   INF                0.003                         
  SERP0099                    ABC transporter, substrate-binding protein                                       INF                0.003                         
  SERP0141       *mfd*        Transcription-repair coupling factor                                                                                   INF        0.001
  SERP0831       *polC*       DNA polymerase III, alpha subunit, Gram-positive type                                                                  INF        0.003
  SERP0240                    Phosphomevalonate kinase                                                                                               INF        0.003
  SERP0358       *fruK*       1-phosphofructokinase                                                                                                  INF        0.003
  SERP0385                    ABC transporter, ATP-binding protein                                                                                   INF        0.003
  SERP1324       *putA*       Proline dehydrogenase                                                                                                  INF        0.058
  SERP0252                    Conserved hypothetical protein                                                                                         INF        0.058
  SERP1901                    Phosphosugar-binding transcriptional regulator, RpiR family                                                            INF        0.003
                                                                                                                                                                

INF, these proteins could not be calculated because the proteins in query was below the detection threshold level for one of the conditions. The proteins expressed in both conditions are marked in bold type.

![GO annotation of differentially expressed proteins of *S. epidermidis* upon α-MG treatment identified using LC-MS/MS analysis. Biological process **(A,C)** and molecular function **(B,D)**.](fmicb-10-00150-g004){#F4}

![KEGG pathway analysis of differentially expressed proteins identified using LC-MS/MS analysis.](fmicb-10-00150-g005){#F5}

Validation of RNA-Sequencing and LC-MS/MS Data by qRT-PCR
---------------------------------------------------------

The transcriptomic and proteomic results were further validated using qRT-PCR. qRT-PCR was performed with RNA isolated from bacteria under the similar experimental conditions used for the RNA-sequencing and LC-MS/MS analysis experiments. A total of 21 genes were selected randomly based on the functional categorization and KEGG pathway analysis. The obtained results were consistent with the transcriptomic and proteomic data ([Figure 6](#F6){ref-type="fig"}), which not only validated the expression profiles of the selected genes, but also substantiated the reliability and accuracy of our transcriptome and proteome analyses. Based on the integrated transcriptome and proteome analyses and further validation through qRT-PCR, it was speculated that α-MG targets *S. epidermidis* through multifarious pathways viz., by principally targeting the cytoplasmic membrane integrity and by subsequently affecting fatty acid biosynthesis, DNA replication, DNA repair machinery, oxidative and cellular stress responses.

![The qRT-PCR validation of differentially expressed genes which are randomly selected based on transcriptomic and proteomic approaches. BRG stands for biofilm regulatory gene. The data represented the mean ± standard deviation of three independent experiments. The statistical significance of data was determined by unpaired Student's *t*-test. ^∗^*P \<* 0.05, ^∗∗^*P \<* 0.005, ^∗∗∗^*P \<* 0.001.](fmicb-10-00150-g006){#F6}

Discussion
==========

The combination of transcriptome and proteome analyses demonstrated a panoramic view of the antibacterial mechanism of α-MG on *S. epidermidis*. [@B26] reported that the rapid bactericidal action of α-MG is comparable with cell membrane lytic cationic antimicrobial peptides (CAMPs). The presence of carbonyl and hydroxyl groups might confer the negative charge to α-MG ([@B1]). Unlike conventional antibiotics that interact with specific targets, many CAMPs bind to anionic bacterial surface and perturb the cyotplasmic membrane ([@B19]). In addition, α-MG is known to interact with transmembrane precursor proteins via hydrogen bonding ([@B56]). In parallel with this report, α-MG strongly downregulated the *yidC2* gene ([Table 1](#T1){ref-type="table"}), which is involved in the integration of nascent membrane protein with dependent from or independent from the Sec-translocase ([@B50]). The proper membrane biogenesis depends on YidC, wherein it acts as a protein insertase, facilitates protein folding, ensues proper topology and an assembly factor for transmembrane proteins ([@B55]). The downregulated gene *yidC2* (encoding a membrane protein insertase) was found to interact with the Sec pathway proteins such as SecA, SecY and FtsY, and the cell division protein FtsQ (encoded by *divlB*). The data from qRT-PCR revealed that *secA, ftsY* and *divlB* were downregulated upon α-MG treatment ([Figure 6](#F6){ref-type="fig"}). Though data on the Sec system of *Staphylococcus* spp. is scarce, *secA* has been shown to be essential for cell viability ([@B22]; [@B23]). The small analogs of Rose Bengal inhibited the *secA1* and *secA2* of *S. aureus* thereby reducing the toxin secretion and bypassing the negative effect of efflux pumps ([@B22]). In addition, MscL (large conductance mechanosensitive channel protein) plays a vital role in protecting cells from osmotic downshock ([@B4]), which was downregulated upon α-MG treatment ([Table 1](#T1){ref-type="table"}). [@B14] suggested that signal recognition particle (SRP) plays an important role in targeting of MscL protein to the cytoplasmic membrane and hence, the deletion of SRP receptor FtsY had a significant effect on the insertion of MscL. Moreover, the depletion of YidC2 inhibits the translocation of protein across the membrane. This confirms that downregulation of YidC2 and FtsY expression could inhibit the insertion of membrane protein MscL. Hence, the downregulation of these very important cytoplasmic membrane associated genes/proteins further corroborate that α-MG elicits bacterial killing by affecting the integrity of cytoplasmic membrane.

α-MG induced the expression level of certain heat-shock proteins (ClpB, ClpC, and GroEL) that ultimately rescue the cells from the lethal effect of α-MG ([Table 1](#T1){ref-type="table"} and [Figure 6](#F6){ref-type="fig"}). In parallel with our observation, the enhanced expression of the *groES* and *groEL* genes was observed upon oxacillin treatment, suggesting that upregulation of these heat-shock protein encoding genes is an integral part of cell wall active-antibiotic stress response ([@B48]). Under stress conditions, the chaperons and heat-shock proteins are capable of reactivating and refolding denatured proteins. Acyldepsipeptides, a new class of antibiotics, activate ClpP to degrade the cell division protein FtsZ, thereby arresting cell division ([@B45]). In line with this report, it was hypothesized that α-MG decrease the expression level of cell division related proteins (FtsY and DivlB) by increasing the Clp protease activity. Further, α-MG treatment increased the expression level of *asp23* encoding the alkaline shock protein ([Table 1](#T1){ref-type="table"} and [Figure 6](#F6){ref-type="fig"}). In *S. aureus*, the transcription of *asp23* is used as a marker for the activity of alternative sigma factor Sigma^B^, which responds to various stress conditions by rapidly increasing its activity ([@B3]; [@B47]; [@B6]). Further, increased expression levels of the oxidative stress response genes, *katA* and *sodA* (encoding catalase and superoxide dismutase, respectively) were observed on α-MG treatment ([Table 1](#T1){ref-type="table"} and [Figure 6](#F6){ref-type="fig"}).

In addition to cytoplasmic membrane perturbation, α-MG seems to target very basic metabolic processes in order to kill the bacteria. Enzymes responsible for DNA replication play an indispensable role in cell growth and are therefore appropriate targets for antimicrobial agents. DNA polymerase I is encoded by the gene *polA* and two other important DNA replication specific enzymes, DNA polymerase III C and DNA polymerase III E are encoded by *polC* and *dnaE*. Both *polC* and *dnaE* are essential for chromosomal DNA replication in Gram-positive bacteria ([@B10]; [@B21]). As reported by [@B21], inactivation of either *polC* or *dnaE* has a bactericidal effect on *S. aureus*. In addition, the downregulated genes *uvrA* and *mfd* have been shown to be involved in nucleotide excision repair machinery. UvrA detects the damaged DNA and the transcription repair coupling factor mfd attract the DNA-excision repair machinery to the damaged DNA ([@B2]). Our transcriptomic and proteomic data shows the downregulation of *polA, polC, dnaE, uvrA*, and *mfd* genes upon α-MG treatment ([Table 2](#T2){ref-type="table"} and [Figure 6](#F6){ref-type="fig"}). Besides, the transcriptomic data shows the downregulation of the *accB* gene encoding a protein that interacts with AccC, AccB, AccA, AccD, FabF, FabG, FabH, FabI, and FabZ proteins ([Table 1](#T1){ref-type="table"}). These proteins are involved in fatty acid biosynthetic pathway (FASII), in which AccB is involved in the first committed step of FASII, catalyzing the formation of malonyl-CoA from acetyl-CoA. The qRT-PCR analysis also demonstrated the downregulation of all the selected genes involved in FASII pathway ([Figure 6](#F6){ref-type="fig"}). In line with our report, platensimycin and platencin were shown to inhibit key FASII enzymes such as FabB/F and/or FabH against *S. aureus, Streptococcus pneumonia, Enterococcus faecalis* and *Enterococcus faecium*, which resulted in bacterial growth inhibition ([@B54], [@B53]; [@B57]). In general, it is hypothesized that α-MG subsided the DNA replication, DNA repair machinery and fatty acid biosynthesis pathway which might further augment the bactericidal property of α-MG against *S. epidermidis.*

Furthermore, our transcriptomic and proteomic data shows the downregulation of *tagG* (encoding the teichoic acid ABC transporter protein) known to be involved in teichoic acids biosynthesis pathway ([Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). The cell wall of gram-positive bacteria is mainly composed of peptidoglycan and Teichoic acids, both of which are important for maintaining the shape and structural integrity of the bacterial cell. Teichoic acids are anomeric polyglycerophosphate chains, which are exported via TagGH, a two component ABC transporter and then, either coupled with peptidoglycan (wall teichoic acids) or anchored from the cytoplasmic membrane (lipoteichoic acids). However, the [D]{.smallcaps}-alanylation modification regulates the interactions between bacterial cell membrane and CAMPs. For instance, increased [D]{.smallcaps}-alanylation of TAs provides resistance to CAMPs, possibly by increasing positive surface charge density. Our transcriptomic data suggested that the expression of *dltA* was clearly downregulated upon α-MG treatment ([Table 1](#T1){ref-type="table"}). The [D]{.smallcaps}-alanylation of TAs is directed by the *dlt* operon, where DltA begins the biosynthetic pathway by activating the [D]{.smallcaps}-alanine from aminoacyl adenylate. [@B33] reported the analog of [D]{.smallcaps}-Ala aminoacyl adenylate as the inhibitor of DltA, that enhanced the susceptibility of *Bacillus subtilis* against cationic antibiotic vancomycin. In line with this report, our previous study signifies that the continuous exposure of α-MG does not induce resistance in planktonic as well as biofilm cells of *S. epidermidis*. This is possibly due to the downregulation of *dltA* which in turn averts positive surface charge density on bacterial membrane and facilitates the interaction between α-MG and bacterial cell membrane. Moreover, *dltA* mutant strain of *S. aureus* is unable to form biofilm on glass or polystyrene, which has been attributed by the inhibition of initial adherence and not accumulation, as the levels of polysaccharide intercellular adhesin (PIA) were unaltered ([@B17]). *S. epidermidis* and *S. aureus* have shown to possess *icaABCD* operon, wherein *icaA* encodes for *N*-acetylglucosaminyltransferase, an enzyme which is important for synthesis of PIA. The proteomic and qRT-PCR analyses showed downregulation of *icaA* which goes in parallel with our previous report ([@B49]), in which a less pronounced biofilm inhibition was observed at sub-MIC of α-MG. Of note, the mode of action of α-MG appears to involve compromising the cytoplasmic membrane integrity of Gram-positive bacteria. The cytoplasmic membrane perturbing ability of α-MG may also add credits in restricting the acquisition of bacterial resistance, as there is evidence suggesting that bacteria do not easily acquire resistance against membrane active antibacterial agents ([@B40]; [@B37]).

Conclusion
==========

Based on the integrated high throughput transcriptomic and proteomic analyses, the antibacterial mode of action of α-MG was identified to be more complex that targets multiple metabolic pathways. It was speculated that the principal target of α-MG seems to be cytoplasmic membrane which further orchestrate the downregulation of genes important for various metabolic pathways. α-MG downregulated the genes involved in FASII pathway, cell division, DNA replication, homologous recombination, mismatch repair, resistance development, biofilm, oxidative stress and cellular stress response, which are believed to be secondary targets of α-MG ([Figure 7](#F7){ref-type="fig"}). As α-MG targets several metabolic pathways, resistance development by the bacterium will be minimal and thus α-MG may be further exploited for clinical trials. To our knowledge, this is one of the very first reports that potentiate the antibacterial activity of α-MG through an integrated transcriptomic and proteomic approach.

![Schematic representation of multifarious antibacterial mode of action for α-MG. **(1)** α-MG shows electrostatic interaction with negatively charged bacterial membrane, where it binds with the bacterial inner membrane **(2)** in which, the strong hydrophobic interaction with lipid alkyl chain of cytoplasmic membrane might be the major driving force for the rapid bactericidal property. Further, α-MG interacts with the transmembrane precursor proteins via hydrogen bonding. **(3)** The downregulation of YidC2, SecA, FtsY, and MscL has evidenced that α-MG thwart the cytoplasmic membrane integrity. **(4)** The downregulation of dltA inhibits [D]{.smallcaps}-alanylation of anomeric teichoic acids and hence, the development of resistance against α-MG has been aborted. **(5)** TagG, a part of two component ABC transporter which exports the anomeric polyglycerophosphate chains (TAs) from cytoplasm. Inhibition of tagG shows that teichoic acid biosynthetic pathway has also been affected, because tagG is localized in cytoplasmic membrane. This might possibly due to the loss of cytoplasmic membrane integrity which resulted in decreased export of teichoic acids from cytoplasm. **(6)** DNA replication and mismatch repair mechanism has been downregulated upon α-MG treatment. **(7)** α-MG also inhibited fatty acid biosynthesis pathway **(8)** α-MG also enhanced the expression of heat shock proteins. **(9)** α-MG has also shown to increase the genes involved in oxidative stress response. CPM, cytoplasmic membrane; PGN, peptidoglycan.](fmicb-10-00150-g007){#F7}

In addition, as α-MG targets multifarious pathway, further in depth analysis viz., mutational and *in vivo* studies on each pathway can be evaluated to identify the primary and secondary targets of α-MG. This will pave the way to develop α-MG as one of the vital drug candidates to treat the infections caused by *S. epidermidis*. Further, combination of any known bioactive compounds or with effective antibiotics not only increases the activity of known bioactive compounds but also can possibly assist the clinical development of these bioactive compounds. Further, combinatorial therapy avoids the resistant development by the bacterial pathogens as it involves the usage of lower/shorter dosing regimens. Hence, combination of α-MG with other well-known phytochemicals or conventional antibiotics can be carried out to evaluate the bactericidal property on mature biofilms.
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